nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—liver cancer	0.465	0.568	CbGaD
Clenbuterol—CYP1A1—liver cancer	0.353	0.432	CbGaD
Clenbuterol—NGF—Signaling Pathways—CTNNB1—liver cancer	2.36e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—H2AFX—liver cancer	2.36e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2—liver cancer	2.36e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CSF2—liver cancer	2.36e-05	0.000129	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PIK3CB—liver cancer	2.33e-05	0.000128	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MMP9—liver cancer	2.32e-05	0.000127	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—CDKN1A—liver cancer	2.31e-05	0.000127	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTA1—liver cancer	2.29e-05	0.000126	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—VEGFA—liver cancer	2.28e-05	0.000125	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NAT2—liver cancer	2.27e-05	0.000124	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—STAT3—liver cancer	2.25e-05	0.000124	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAPK8—liver cancer	2.25e-05	0.000124	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADAM17—liver cancer	2.21e-05	0.000121	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.18e-05	0.00012	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALDOB—liver cancer	2.17e-05	0.000119	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ADAM17—liver cancer	2.16e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2—liver cancer	2.14e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TERT—liver cancer	2.14e-05	0.000117	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—TGFB1—liver cancer	2.09e-05	0.000115	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—F2—liver cancer	2.08e-05	0.000114	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—VEGFA—liver cancer	2.08e-05	0.000114	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PSMA4—liver cancer	2.08e-05	0.000114	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PSMD10—liver cancer	2.08e-05	0.000114	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CRABP1—liver cancer	2.07e-05	0.000114	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—STAT3—liver cancer	2.06e-05	0.000113	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—F2—liver cancer	2.04e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PSMD10—liver cancer	2.03e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PSMA4—liver cancer	2.03e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CG—liver cancer	1.99e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KDR—liver cancer	1.95e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CG—liver cancer	1.95e-05	0.000107	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	1.94e-05	0.000107	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK14—liver cancer	1.94e-05	0.000106	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—KRAS—liver cancer	1.94e-05	0.000106	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MYC—liver cancer	1.91e-05	0.000105	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TGFB1—liver cancer	1.91e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ESR1—liver cancer	1.9e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—F2—liver cancer	1.89e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—F2—liver cancer	1.88e-05	0.000103	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.87e-05	0.000102	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—F2—liver cancer	1.85e-05	0.000101	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—HPGDS—liver cancer	1.81e-05	9.94e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CG—liver cancer	1.81e-05	9.92e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.8e-05	9.88e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APC—liver cancer	1.8e-05	9.87e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CG—liver cancer	1.8e-05	9.87e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CPT1B—liver cancer	1.79e-05	9.84e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GLUL—liver cancer	1.79e-05	9.84e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CG—liver cancer	1.77e-05	9.7e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—KRAS—liver cancer	1.77e-05	9.7e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CD—liver cancer	1.75e-05	9.6e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NR1H4—liver cancer	1.73e-05	9.49e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CD—liver cancer	1.71e-05	9.39e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTA3—liver cancer	1.7e-05	9.33e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—BRAF—liver cancer	1.69e-05	9.28e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—HRAS—liver cancer	1.65e-05	9.03e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.64e-05	9e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PIK3CA—liver cancer	1.62e-05	8.91e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.62e-05	8.89e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PSMD10—liver cancer	1.62e-05	8.86e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PSMA4—liver cancer	1.62e-05	8.86e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRKCE—liver cancer	1.61e-05	8.82e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CD—liver cancer	1.59e-05	8.72e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CD—liver cancer	1.58e-05	8.68e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—liver cancer	1.58e-05	8.64e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRKCE—liver cancer	1.57e-05	8.63e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TP53—liver cancer	1.57e-05	8.62e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GOT2—liver cancer	1.57e-05	8.62e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—PIK3CA—liver cancer	1.57e-05	8.6e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SERPINE1—liver cancer	1.56e-05	8.58e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CD—liver cancer	1.55e-05	8.53e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTA4—liver cancer	1.55e-05	8.53e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—KRAS—liver cancer	1.55e-05	8.5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CB—liver cancer	1.53e-05	8.37e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF2—liver cancer	1.52e-05	8.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.52e-05	8.34e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTA2—liver cancer	1.52e-05	8.31e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRAS—liver cancer	1.5e-05	8.25e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CB—liver cancer	1.49e-05	8.19e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF2—liver cancer	1.49e-05	8.17e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP2E1—liver cancer	1.48e-05	8.1e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTA1—liver cancer	1.46e-05	8.02e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—AKT1—liver cancer	1.45e-05	7.97e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NAT2—liver cancer	1.45e-05	7.93e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—liver cancer	1.44e-05	7.89e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.43e-05	7.85e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PIK3CA—liver cancer	1.42e-05	7.81e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CSF2—liver cancer	1.42e-05	7.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—RAF1—liver cancer	1.42e-05	7.78e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—RAF1—liver cancer	1.41e-05	7.75e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—H2AFX—liver cancer	1.4e-05	7.69e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—liver cancer	1.4e-05	7.69e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CSF2—liver cancer	1.39e-05	7.63e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.39e-05	7.62e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—RAF1—liver cancer	1.39e-05	7.61e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALDOB—liver cancer	1.39e-05	7.6e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CB—liver cancer	1.39e-05	7.6e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYCS—liver cancer	1.38e-05	7.58e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MTOR—liver cancer	1.38e-05	7.56e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CB—liver cancer	1.38e-05	7.56e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—H2AFX—liver cancer	1.37e-05	7.52e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—liver cancer	1.37e-05	7.52e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GOT1—liver cancer	1.36e-05	7.44e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GGT1—liver cancer	1.36e-05	7.44e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CB—liver cancer	1.36e-05	7.43e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—AKT1—liver cancer	1.33e-05	7.28e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CRABP1—liver cancer	1.32e-05	7.25e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRAS—liver cancer	1.32e-05	7.22e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1B—liver cancer	1.29e-05	7.1e-05	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—AKT1—liver cancer	1.28e-05	7.02e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—liver cancer	1.27e-05	6.98e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CASP3—liver cancer	1.27e-05	6.96e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TERT—liver cancer	1.27e-05	6.95e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—liver cancer	1.27e-05	6.95e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—liver cancer	1.26e-05	6.91e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—liver cancer	1.24e-05	6.83e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TERT—liver cancer	1.24e-05	6.8e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CCND1—liver cancer	1.23e-05	6.77e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—JUN—liver cancer	1.23e-05	6.76e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CTNNB1—liver cancer	1.22e-05	6.71e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTP1—liver cancer	1.22e-05	6.68e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—HMOX1—liver cancer	1.2e-05	6.59e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MMP9—liver cancer	1.2e-05	6.57e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CDKN1A—liver cancer	1.19e-05	6.55e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.19e-05	6.53e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK8—liver cancer	1.17e-05	6.39e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—AKT1—liver cancer	1.16e-05	6.38e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KDR—liver cancer	1.16e-05	6.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HPGDS—liver cancer	1.16e-05	6.34e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK14—liver cancer	1.15e-05	6.32e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.15e-05	6.3e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KDR—liver cancer	1.13e-05	6.22e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ESR1—liver cancer	1.13e-05	6.2e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK14—liver cancer	1.13e-05	6.18e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTM1—liver cancer	1.12e-05	6.14e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—F2—liver cancer	1.12e-05	6.12e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ESR1—liver cancer	1.11e-05	6.06e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—F2—liver cancer	1.09e-05	5.99e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—VEGFA—liver cancer	1.08e-05	5.9e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APC—liver cancer	1.07e-05	5.86e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CG—liver cancer	1.07e-05	5.86e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—STAT3—liver cancer	1.07e-05	5.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.05e-05	5.74e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CG—liver cancer	1.04e-05	5.73e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APC—liver cancer	1.04e-05	5.73e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.03e-05	5.67e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PSMA4—liver cancer	1.03e-05	5.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PSMD10—liver cancer	1.03e-05	5.65e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—BRAF—liver cancer	1e-05	5.51e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GOT2—liver cancer	1e-05	5.5e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MYC—liver cancer	9.9e-06	5.43e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MTHFR—liver cancer	9.89e-06	5.43e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TGFB1—liver cancer	9.88e-06	5.42e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—BRAF—liver cancer	9.82e-06	5.39e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARA—liver cancer	9.71e-06	5.33e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP2E1—liver cancer	9.42e-06	5.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CD—liver cancer	9.39e-06	5.15e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CA—liver cancer	9.3e-06	5.1e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SERPINE1—liver cancer	9.29e-06	5.09e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—KRAS—liver cancer	9.19e-06	5.04e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CD—liver cancer	9.18e-06	5.04e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—KRAS—liver cancer	9.15e-06	5.02e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.12e-06	5e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CA—liver cancer	9.1e-06	4.99e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SERPINE1—liver cancer	9.08e-06	4.98e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—KRAS—liver cancer	8.99e-06	4.93e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYCS—liver cancer	8.81e-06	4.83e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.72e-06	4.78e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GOT1—liver cancer	8.65e-06	4.74e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GGT1—liver cancer	8.65e-06	4.74e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CA—liver cancer	8.45e-06	4.63e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CA—liver cancer	8.41e-06	4.61e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—RAF1—liver cancer	8.38e-06	4.6e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CG—liver cancer	8.31e-06	4.56e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CA—liver cancer	8.26e-06	4.53e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—RAF1—liver cancer	8.2e-06	4.5e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CB—liver cancer	8.18e-06	4.49e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MTOR—liver cancer	8.18e-06	4.49e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TP53—liver cancer	8.13e-06	4.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PPARG—liver cancer	8.02e-06	4.4e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CB—liver cancer	8.01e-06	4.39e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MTOR—liver cancer	8.01e-06	4.39e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRAS—liver cancer	7.81e-06	4.29e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRAS—liver cancer	7.78e-06	4.27e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTP1—liver cancer	7.77e-06	4.26e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1B—liver cancer	7.68e-06	4.21e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—HMOX1—liver cancer	7.66e-06	4.2e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRAS—liver cancer	7.64e-06	4.19e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AKT1—liver cancer	7.6e-06	4.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CASP3—liver cancer	7.53e-06	4.13e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—liver cancer	7.52e-06	4.12e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1B—liver cancer	7.51e-06	4.12e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—liver cancer	7.48e-06	4.1e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—liver cancer	7.44e-06	4.08e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AKT1—liver cancer	7.43e-06	4.08e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CASP3—liver cancer	7.36e-06	4.04e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—liver cancer	7.35e-06	4.03e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CCND1—liver cancer	7.33e-06	4.02e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—liver cancer	7.32e-06	4.01e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—JUN—liver cancer	7.31e-06	4.01e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CD—liver cancer	7.31e-06	4.01e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CTNNB1—liver cancer	7.26e-06	3.98e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ALB—liver cancer	7.21e-06	3.96e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CCND1—liver cancer	7.17e-06	3.93e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—JUN—liver cancer	7.15e-06	3.92e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM1—liver cancer	7.14e-06	3.92e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MMP9—liver cancer	7.11e-06	3.9e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CTNNB1—liver cancer	7.1e-06	3.89e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CDKN1A—liver cancer	7.09e-06	3.89e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MMP9—liver cancer	6.96e-06	3.82e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CDKN1A—liver cancer	6.93e-06	3.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK8—liver cancer	6.92e-06	3.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AKT1—liver cancer	6.9e-06	3.78e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AKT1—liver cancer	6.87e-06	3.77e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP1A1—liver cancer	6.77e-06	3.71e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK8—liver cancer	6.77e-06	3.71e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AKT1—liver cancer	6.75e-06	3.7e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VEGFA—liver cancer	6.39e-06	3.5e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CB—liver cancer	6.37e-06	3.49e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—STAT3—liver cancer	6.32e-06	3.47e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MTHFR—liver cancer	6.31e-06	3.46e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VEGFA—liver cancer	6.25e-06	3.43e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARA—liver cancer	6.19e-06	3.4e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—STAT3—liver cancer	6.19e-06	3.39e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MYC—liver cancer	5.88e-06	3.22e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TGFB1—liver cancer	5.86e-06	3.22e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MYC—liver cancer	5.75e-06	3.15e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TGFB1—liver cancer	5.73e-06	3.15e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.56e-06	3.05e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—KRAS—liver cancer	5.43e-06	2.98e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—KRAS—liver cancer	5.31e-06	2.91e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CG—liver cancer	5.3e-06	2.91e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PPARG—liver cancer	5.12e-06	2.81e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CA—liver cancer	4.99e-06	2.74e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CA—liver cancer	4.88e-06	2.68e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TP53—liver cancer	4.83e-06	2.65e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TP53—liver cancer	4.72e-06	2.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CD—liver cancer	4.66e-06	2.56e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRAS—liver cancer	4.62e-06	2.53e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ALB—liver cancer	4.6e-06	2.52e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRAS—liver cancer	4.52e-06	2.48e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—liver cancer	4.42e-06	2.42e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—liver cancer	4.32e-06	2.37e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AKT1—liver cancer	4.08e-06	2.24e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CB—liver cancer	4.06e-06	2.23e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AKT1—liver cancer	3.99e-06	2.19e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CA—liver cancer	3.88e-06	2.13e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—AKT1—liver cancer	3.17e-06	1.74e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CA—liver cancer	2.48e-06	1.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—AKT1—liver cancer	2.02e-06	1.11e-05	CbGpPWpGaD
